Fresh analysis indicates that patients who come off new GLP-1 drugs like Wegovy and Mounjaro can put back on shed pounds far faster than those who halt traditional lifestyle programs.
Published data in a leading health publication points out that while overweight individuals often shed substantial amounts of their body weight while undergoing treatment, the weight comes back at an estimated rate of 0.8 kg per month upon discontinuation.
"Users purchasing such drugs must be aware of the risk of rapid weight regain when the medication ends," cautioned lead investigator Dr. Susan Jebb.
This pace of recovery implies a return to starting weight in about one and a half years.
Weighing Therapies
The research, which reviewed dozens of studies involving thousands of participants, contrasted the effects of these new drugs with other pills.
Scientists emphasize that people who lose weight through lifestyle changes alone typically experience a more gradual weight regain—perhaps 0.1 kg a month—post-intervention.
Understanding the Rapid Rebound
Experts suggest the mechanism of the drugs is key to understanding the amplified regain.
The injections imitate a body's own chemical called glucagon-like peptide-1, which moderates hunger.
"Long-term administration of GLP-1 concentrations several times higher than normal might result in the system to produce less of its own natural GLP-1, and may also diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this GLP-1 'fix' means hunger is no longer kept in check, making excessive eating far more likely."
A Lifelong Issue?
Health authorities advise the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, given the significant potential of weight regain, the treatment is often ongoing.
This view is reinforced by drug manufacturers, who note that the results "emphasize the persistent nature of obesity," akin to managing diseases like high blood pressure.
User Experiences
People who have discontinued the jabs explain a sudden resurgence of cravings.
"It was like a switch activating and you become starving," described a patient.
This difficulty is worsened if users have not established sustainable dietary or behavioural changes during treatment.
Significant Use
Figures suggest that a significant number of adults in the UK have tried weight-loss jabs in the past year, with desire continuing to grow.
- Adoption is greater among women than males.
- The 40s and 50s demographic shows the highest usage rates.
- Many obtain the drugs through private healthcare rather than the NHS.
Ultimately, experts emphasize that while these medications are powerful tools for shedding pounds, they are not a magic solution and lasting health benefits likely depends on combined behavioural changes.
